Kelly Lowensen

Datos Biográficos

ID7733087
NOMBREKelly Lowensen
NOMBRESKelly
APELLIDOLowensen
FIRMALOWENSEN K
AFILIACIONESJohns Hopkins University
VERIFICADONo
TOTAL DE OBRAS6
TOTAL DE CITAS0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • Missed PrEP opportunities and vulnerability to HIV during rifampicin-resistant tuberculosis treatment in South Africa

    Open AccessAdam Leonard, Kelly Lowensen et al.ARTICLEFrontiers in Public Health2026

    Background: Adults receiving rifampicin-resistant TB (RR-TB) treatment have prolonged engagement with the health system, yet healthcare professionals frequently miss opportunities to promote HIV prevention-particularly pre-exposure prophylaxis (PrEP)-in high-burden settings. We examined HIV vulnerability, PrEP awareness and uptake, and HIV and sexually transmitted infection (STI) incidence among HIV-negative adults receiving RR-TB treatment. Meth…

  • Stigma and Time

    Open AccessAmanda J Bergman, Michael V Relf et al.ARTICLEAIDS and Behavior2025

    For people with HIV and tuberculosis (TB), stigma may change over time. Identifying time points when individuals are most likely to experience HIV or TB related stigma, or when stigma begins to abate, may be useful in tailoring stigma-reduction interventions in resource-limited settings. This study used longitudinal qualitative data to explore if and how HIV and TB stigma change over the course of treatment. People living with HIV and rifampicin-…

  • Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes

    Open AccessKeri Geiger, Amita Patil et al.ARTICLEPLOS Global Public Health2024

    The impact of HIV viral suppression on multidrug resistant tuberculosis (MDR-TB) treatment outcomes among people with HIV (PWH) has not been clearly established. Using secondary data from a cluster-randomized clinical trial among people with MDR-TB in South Africa, we examined the effects of HIV viral suppression at MDR-TB treatment initiation and throughout treatment on MDR-TB outcomes among PWH using multinomial regression. This analysis includ…

  • Cognitive dissonance in tuberculosis stigma

    Open AccessAmanda J Bergman, Chakra Budhathoki et al.ARTICLEPLOS Global Public Health2024

    Background The Patient and Community Perspectives Towards Tuberculosis are the most common measure of tuberculosis (TB) stigma in sub-Saharan Africa. The instrument and its sub-scales (patient and community) have been quantitatively validated but have not undergone qualitative exploration in South Africa. Methods We explored whether the Patient Perspectives Towards Tuberculosis adequately represents stigma as experienced by people with TB in Sout…

  • Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up

    Open AccessKatherine McNabb, Katherine C McNabb et al.ARTICLEBMC Public Health2024

    People living in KwaZulu-Natal and Eastern Cape travel long distances to receive RR-TB care, placing them at increased risk for LTFU. Policies that bring RR-TB treatment closer to patients, such as further decentralization to PHCs, are necessary to improve RR-TB outcomes

  • The impact of stigma and sexual identity on PrEP awareness and use among at-risk men who have sex with men in four U.S. cities (HPTN 078)

    Open AccessJason E Farley, Geetha Beuchamp et al.ARTICLEStigma and Health2022

    Persistent pre-exposure prophylaxis (PrEP) use reduces the risk of HIV infection, yet uptake lags among those with the greatest need. Sexual identity stigma may be a significant barrier to PrEP awareness and use among high-risk communities. The primary aim of this study was to determine whether sexual identity was related to PrEP awareness and use. This multi-site HIV Prevention Trials Network (HPTN) study (HPTN 078) focuses on men who have sex w…